Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $7.40 and traded as low as $6.55. Neuberger Berman High Yield Strategies Fund shares last traded at $6.59, with a volume of 640,152 shares trading hands.
Neuberger Berman High Yield Strategies Fund Stock Performance
The company has a 50 day moving average price of $7.44 and a 200 day moving average price of $7.40.
Neuberger Berman High Yield Strategies Fund Dividend Announcement
The business also recently disclosed a monthly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, April 7th will be given a dividend of $0.0905 per share. This represents a c) dividend on an annualized basis and a yield of 16.5%. The ex-dividend date of this dividend is Tuesday, April 7th.
Hedge Funds Weigh In On Neuberger Berman High Yield Strategies Fund
Several institutional investors and hedge funds have recently modified their holdings of the stock. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Neuberger Berman High Yield Strategies Fund during the 3rd quarter worth about $80,000. Integrity Advisory Solutions LLC acquired a new position in Neuberger Berman High Yield Strategies Fund in the 4th quarter valued at about $81,000. CoreCap Advisors LLC bought a new position in Neuberger Berman High Yield Strategies Fund in the 3rd quarter valued at about $94,000. XTX Topco Ltd bought a new position in Neuberger Berman High Yield Strategies Fund in the 2nd quarter valued at about $113,000. Finally, MRA Advisory Group lifted its position in Neuberger Berman High Yield Strategies Fund by 10.9% during the third quarter. MRA Advisory Group now owns 17,261 shares of the investment management company's stock worth $129,000 after acquiring an additional 1,693 shares during the last quarter.
About Neuberger Berman High Yield Strategies Fund
(
Get Free Report)
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Neuberger Berman High Yield Strategies Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neuberger Berman High Yield Strategies Fund wasn't on the list.
While Neuberger Berman High Yield Strategies Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.